Fort Lee, New Jersey, USA, Jan. 8, 2015 (GLOBE NEWSWIRE) -- Herborium® Group,
Inc.(OTC Pink: HBRM),
www.Herborium.com, a
Botanical Therapeutics® Company providing unique, all
botanical medicines (Botanical Therapeutics®), announced today that
its Amazon sales grew 54% over sales for the same period in
2013. This very significant increase in revenue results from
a 25% increase in the number of orders and a 37% increase in the
average value of the order. The increase in the average value of
the order is especially significant since it indicates a growing
consumer confidence in Herborium and its products.
The overall growth in revenues, increase in number of customers
and the average order value for Amazon based sales represent a
pivotal factor in Herborium's decision to join Amazon in Europe
through its UK Gateway in the first quarter of 2015. Amazon
sales in Europe surpassed $20 billion and are growing on average
20% a year since 2011.
"Herborium's Amazon US sales growth in 2014 confirms our
expectations for a very successful end of 2014. Company's
financial results for 2014 should be announced shortly.
We expect the growth and profitability of our novel, all natural
medicines - Botanical Therapeutics®" to continue in 2015 ",
commented Dr. Agnes P. Olszewski, CEO and Chairwoman of Herborium
Group.
About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics® company that
develops, license and markets proprietary, botanical based
medicinal products to consumers and healthcare professionals. The
Company business model focuses on emerging market opportunities
spearheaded by the growth of a new market sector located between
high-cost, high-risk, ethical pharmaceuticals and commoditized
classic nutraceuticals (supplements). The Company uses
clinical validation and a proactive regulatory strategy based on
the FDA Guidance for Industry: Botanical Drug Products
(FDA Guidance 2004) to establish and maintain a
differential advantage. Herborium has secured a pipeline of
botanical ingredients based products in the areas of dermatological
needs, wellness and energy, prostate health, women's health and
selected sexual disorders resulting from cardiovascular disease,
use of anti-depressants, diabetes, surgical procedures, and other
problems. Herborium Group sells its products in the United States,
the United Kingdom, and continental Europe through a network of
distributors, specialty retailers, and e-commerce. For more
information, please visit www.herborium.com, and www.acnease.com.
Safe Harbor Statement: This release contains
forward-looking statements with respect to the results of
operations and business of Herborium Group, Inc., which involves
risks and uncertainties. The Company's actual future results
could materially differ from those discussed. The Company
intends that such statements about the Company's future
expectations, including future revenues and earnings, and all other
forward looking statements be subject to the "Safe Harbors"
provision of the Private Securities Litigation Reform Act of
1995.
CONTACT: Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com
Tel.201.849.4431